Pablo J. Cagnoni, M.D. has been promoted to vice president and chief medical officer, OSI Pharmaceuticals, Inc. In this position, Dr. Cagnoni will oversee all of the clinical development and medical affairs activities of the company’s oncology portfolio, which includes further development of Tarceva. Dr. Cagnoni has also been appointed as an officer of the corporation and will serve as a member of the company’s executive management committee. “Pablo has shown excellent lea...